HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells

International Immunology

Volumn 24, Issue 8, 2012, Pages 485-494

  Wild, Clarissa Anni ^a   Bergmann, Christoph ^a   Fritz, Günter ^b   Schuler, Patrick ^a   Hoffmann, Thomas K ^a   Lotfi, Ramin ^c   Westendorf, Astrid ^a   Brandau, Sven ^a   Lang, Stephan ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Danger signals; Immunosuppression; RAGE; TLR4; Tolerance

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CD4 ANTIGEN; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TOLL LIKE RECEPTOR 4;

ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL LEVEL; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOREACTIVITY; INTRACELLULAR SIGNALING; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SUPERNATANT; T LYMPHOCYTE;

APOPTOSIS; CELL SEPARATION; CELL SURVIVAL; CHEMOTAXIS, LEUKOCYTE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HMGB1 PROTEIN; HUMANS; IMMUNE TOLERANCE; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TUMOR ESCAPE;

EID: 84865084552     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs051     Document Type: Article

References (54)

1. Bustin, M. 1999. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell Biol. 19:5237.
2. Ellerman, J. E., Brown, C. K., de, V. M. et al. 2007. Masquerader: high mobility group box-1 and cancer. Clin. Cancer Res. 13:2836.
3. Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R. and Coyle, A. J. 2010. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 28:367.
4. Wang, H., Bloom, O., Zhang, M. et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248.
5. Dumitriu, I. E., Baruah, P., Valentinis, B. et al. 2005. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J. Immunol. 174:7506.
6. Wang, H., Vishnubhakat, J. M., Bloom, O. et al. 1999. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126:389.
7. Rauvala, H. and Pihlaskari, R. 1987. Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J. Biol. Chem. 262:16625.
8. Palumbo, R., Sampaolesi, M., de, M. F. et al. 2004. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 164:441.
9. Bottger, M., Vogel, F., Platzer, M., Kiessling, U., Grade, K. and Strauss, M. 1988. Condensation of vector DNA by the chromosomal protein HMG1 results in efficient transfection. Biochim. Biophys. Acta 950:221.
10. Sloots, A. and Wels, W. S. 2005. Recombinant derivatives of the human high-mobility group protein HMGB2 mediate efficient nonviral gene delivery. FEBS J. 272:4221.
11. Kostova, N., Zlateva, S., Ugrinova, I. and Pasheva, E. 2010. The expression of HMGB1 protein and its receptor RAGE in human malignant tumors. Mol. Cell Biochem. 337:251.
12. Chung, H. W., Lee, S. G., Kim, H. et al. 2009. Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer. J. Transl. Med. 7:38.
13. Kokkola, R., Sundberg, E., Ulfgren, A. K. et al. 2002. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum. 46:2598.
14. Messmer, D., Yang, H., Telusma, G. et al. 2004. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 173:307.
15. Popovic, P. J., DeMarco, R., Lotze, M. T. et al. 2006. High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists. J. Immunol. 177:8701.
16. Orlova, V. V., Choi, E. Y., Xie, C. et al. 2007. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 26:1129.
17. Lotfi, R., Herzog, G. I., DeMarco, R. A. et al. 2009. Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells. J. Immunol. 183:5023.
18. Andersson, U., Wang, H., Palmblad, K. et al. 2000. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192:565.
19. Park, J. S., Arcaroli, J., Yum, H. K. et al. 2003. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 284:C870.
20. Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330.
21. Dejaco, C., Duftner, C., Grubeck-Loebenstein, B. and Schirmer, M. 2006. Imbalance of regulatory T cells in human autoimmune diseases. Immunology 117:289.
22. Strauss, L., Bergmann, C., Gooding, W., Johnson, J. T. and Whiteside, T. L. 2007. The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin. Cancer Res. 13:6301.
23. Rovere-Querini, P., Capobianco, A., Scaffidi, P. et al. 2004. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 5:825.
24. Heo, D. S., Snyderman, C., Gollin, S. M. et al. 1989. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res. 49:5167.
25. Livak, K. J. and Schmittgen, T. D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402.
26. Youn, J. H., Oh, Y. J., Kim, E. S., Choi, J. E. and Shin, J. S. 2008. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J. Immunol. 180:5067.
27. Koch, M., Chitayat, S., Dattilo, B. M. et al. 2010. Structural basis for ligand recognition and activation of RAGE.. Structure 18:1342.
28. Liu, S., Tobias, R., McClure, S., Styba, G., Shi, Q. and Jackowski, G. 1997. Removal of endotoxin from recombinant protein preparations. Clin. Biochem. 30:455.
29. Rouhiainen, A., Tumova, S., Valmu, L., Kalkkinen, N. and Rauvala, H. 2007. Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J. Leukoc. Biol. 81:4958.
30. Wild, C. A., Brandau, S., Lindemann, M. et al. 2010. Toll-like receptors in regulatory T Cells of patients with head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 136:1253.
31. Palumbo, R. and Bianchi, M. E. 2004. High mobility group box 1 protein, a cue for stem cell recruitment. Biochem. Pharmacol. 68:1165.
32. Pisetsky, D. S., Erlandsson-Harris, H. and Andersson, U. 2008. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res. Ther. 10:209.
33. Brezniceanu, M. L., Volp, K., Bosser, S. et al. 2003. HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB J. 17:1295.
34. Volp, K., Brezniceanu, M. L., Bosser, S. et al. 2006. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 55:234.
35. Mitola, S., Belleri, M., Urbinati, C. et al. 2006. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J. Immunol. 176:12.
36. Sundberg, E., Fasth, A. E., Palmblad, K., Harris, H. E. and Andersson, U. 2009. High mobility group box chromosomal protein 1 acts as a proliferation signal for activated T lymphocytes. Immunobiology 214:303.
37. Han, J., Zhong, J., Wei, W. et al. 2008. Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice. Diabetes 57:2118.
38. Iwasaki, A. and Medzhitov, R. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5:987.
39. Gonzalez-Navajas, J. M., Fine, S., Law, J. et al. 2010. TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice. J. Clin. Invest. 120:570.
40. Yang, D., Chen, Q., Yang, H., Tracey, K. J., Bustin, M. and Oppenheim, J. J. 2007. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J. Leukoc. Biol. 81:59.
41. Taguchi, A., Blood, D. C., del, T. G. et al. 2000. Blockade of RAGEamphoterin signalling suppresses tumour growth and metastases. Nature 405:354.
42. DiNorcia, J., Moroziewicz, D. N., Ippagunta, N. et al. 2010. RAGE signaling significantly impacts tumorigenesis and hepatic tumor growth in murine models of colorectal carcinoma. J. Gastrointest. Surg. 14:1680.
43. Huang, L. F., Yao, Y. M., Zhang, L. T., Dong, N., Yu, Y. and Sheng, Z. Y. 2009. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats. Shock 31:322.
44. Bianchi, M. E. 2009. HMGB1 loves company. J. Leukoc. Biol. 86:573.
45. Liu, Z., Falo, L. D., Jr and You, Z. 2011. Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunity. J. Immunol. 187:118.
46. Sutmuller, R. P., den Brok, M. H., Kramer, M. et al. 2006. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116:485.
47. Boissier, M. C., Assier, E., Biton, J., Denys, A., Falgarone, G. and Bessis, N. 2009. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 76:10.
48. Barreto, M., Ferreira, R. C., Lourenco, L. et al. 2009. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants. BMC Immunol. 10:5.
49. Sparvero, L. J., Safu-Adjei, D., Kang, R. et al. 2009. RAGE (receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation. J. Transl. Med. 7:17.
50. Tang, D., Kang, R., Livesey, K. M. et al. 2010. Endogenous HMGB1 regulates autophagy. J. Cell Biol. 190:881.
51. Tang, D., Kang, R., Zeh, H. J. III and Lotze, M. T. 2011. Highmobility group box 1, oxidative stress, and disease. Antioxid. Redox. Signal. 14:1315.
52. Tang, D., Kang, R., Cheh, C. W. et al. 2010. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 29:5299.
53. Amaravadi, R. K., Lippincott-Schwartz, J., Yin, X. M. et al. 2011. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res. 17:654.
54. Tang, D., Kang, R., Livesey, K. M. et al. 2011. High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab. 13:701.